Effect of bosentan therapy in persistent pulmonary hypertension of the newborn

• Glavni autori: Gunlawadee Maneenil (Autor), Anucha Thatrimontrichai (Autor), Waricha Janjindamai (Autor), Supaporn Dissaneevate (Autor)
• Format: Knjiga
• Izdano: Elsevier, 2018-02-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Background: Persistent pulmonary hypertension of the newborn (PPHN) contributes to neonatal hypoxemia and is associated with a high mortality. Some PPHN patients are unresponsive to inhaled nitric oxide (iNO). Bosentan, an oral endothelin-1 receptor antagonist, reduces pulmonary vascular resistance...